# HeartBeam (BEAT) on the Beat of Cardiac Innovation

LOS ANGELES, CA - October 9, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. A recent article discussing this reads, “HeartBeam plans to initiate commercialization immediately upon receiving FDA clearance. The company’s vision is to empower patients and healthcare providers by offering a portable, cable-free ECG solution that combines clinical-grade accuracy with ease of use. This innovation is poised to reduce the burden on healthcare facilities, improve patient engagement, and increase the availability of high-quality cardiac monitoring, particularly in underserved areas or for patients requiring frequent arrhythmia assessments.”

 To view the full article, visit https://ibn.fm/kj3zb

 About HeartBeam Inc.

 HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care - all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. For more information, visit www.HeartBeam.com.

 Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

 Forward Looking Statements

 Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. 

---

[Original/Source Press Release](https://www.newmediawire.com/news/heartbeam-beat-on-the-beat-of-cardiac-innovation-7083297)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/heartbeam-s-cable-free-ecg-tech-set-to-revolutionize-cardiac-care/85e114e1fc2c70bfd57b2431ca813b7c) 


Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202510/248378-heartbeam-revoluciona-el-diagnostico-cardiaco-con-tecnologia-ecg-portatil-sin-cables)
 

 



![Blockchain Registration](https://cdn.newsramp.app/newmediawire/qrcode/2510/9/noonWaZO.webp)